Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease

NCT03250741 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Rotigotine transdermal patch
OTHER: Placebo

Sponsor

I.R.C.C.S. Fondazione Santa Lucia